logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (vii) Percentage distribution of all inpatient clients by age at first use for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates6.542.228.712.35.92.61.20.721.8126581166
Cocaine5.748.424.610.76.22.51.30.721.63271374
Stimulants16.559.715.34.82.10.80.40.318.86081527
Hypnotics and sedatives7.727.521.614.3106.14.97.926.42552447
Hallucinogens12.367.114.93.81.50.20.2018.5135490
Volatile substances55.137.651.20.50.50015.956122
Cannabis 37.446.59.13.21.81.10.50.317.56770812
Other substances 13.237.215.59.47.46.13.18.124.63931324
Total15.646.620.38.54.52.21.21.120.5336404762

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU, AT, RO, SK, FI, SE, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008